Σύγκριση μεθόδων
Εξετάστε τις επιλεγμένες μεθόδους δίπλα-δίπλα· οι γραμμές που διαφέρουν επισημαίνονται.
| Εκτιμητής Αντιστοίχισης Ενισχυμένος με Μηχανική Μάθηση× | Αντιστοίχιση Βαθμολογίας Προδιάθεσης× | |
|---|---|---|
| Πεδίο≠ | Αιτιακή Συμπερασματολογία | Ερευνητική Στατιστική |
| Οικογένεια≠ | Regression model | Process / pipeline |
| Έτος προέλευσης≠ | 2006–2018 | 1983 |
| Δημιουργός≠ | Abadie & Imbens (classical matching); Chernozhukov et al. (ML augmentation framework) | Paul Rosenbaum and Donald Rubin |
| Τύπος≠ | Causal inference / nonparametric matching | Method |
| Θεμελιώδης πηγή≠ | Chernozhukov, V., Chetverikov, D., Demirer, M., Duflo, E., Hansen, C., Newey, W., & Robins, J. (2018). Double/debiased machine learning for treatment and structural parameters. The Econometrics Journal, 21(1), C1-C68. DOI ↗ | Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70(1), 41–55. DOI ↗ |
| Εναλλακτικές ονομασίες≠ | ML-augmented matching, ML matching estimator, high-dimensional matching estimator, data-adaptive matching estimator | PSM, propensity score weighting, covariate balance |
| Συναφείς≠ | 5 | 3 |
| Σύνοψη≠ | The machine learning-augmented matching estimator combines classical nearest-neighbor or propensity-score matching with ML algorithms — such as lasso, random forests, or gradient boosting — to select covariates, estimate propensity scores, and correct for residual bias. The result is a matching-based causal estimator that remains valid under high-dimensional confounding where traditional hand-specified matching fails. | Propensity score matching (PSM) is a method for reducing confounding bias in observational studies by balancing baseline characteristics between treatment groups, simulating randomization. Developed by Rosenbaum and Rubin (1983), it estimates the probability of receiving treatment given observed covariates, then matches or weights treated and control individuals with similar treatment probabilities. Widely used in medicine, epidemiology, and policy evaluation when randomized trials are infeasible or unethical, enabling estimation of treatment effects while controlling for selection bias. |
| ScholarGateΣύνολο δεδομένων ↗ |
|
|